Mindmed to participate in the canaccord genuity 42nd annual growth conference

New york , aug. 2, 2022 /prnewswire/ -- mind medicine (mindmed) inc. (nasdaq: mnmd), (neo: mmed), (the "company" or "mindmed"), a clinical stage biopharmaceutical company developing novel products to treat brain health disorders, today announced that members of mindmed's management team will participate in the canaccord genuity 42nd annual growth conference, to be held in boston, ma, august 8-11, 2022. canaccord genuity 42nd annual growth conference format: in-person presentation and scheduled one-on-one investor meetingsdate: wednesday, august 10, 2022 time: 11:00 a.m.
MNMD Ratings Summary
MNMD Quant Ranking